In contrast, monthly expenditure of the basic medical insurance funds on inpatient services showed a decreasing trend (β 1 + β 13 = −42.6554, P = .243), while the monthly expenditure of the basic medical insurance funds on medical services exhibited an upward trend (β 1 + β 13 = 3.0967, P = .413), neither trend was statistically significant.
← all phrases
“a decreasing trend”
Sighted at
p=0.09
In the literature
During the pre-intervention period, a trend in time-to-isolation nearly plateaued (1.0 h/month; 95% CI − 1.7, 3.7; p = 0.462), whereas a significant decrease in time-to-isolation (− 41.9 h; 95% CI − 82.2, − 1.7; p = 0.041) at the intervention point was observed, and a decreasing trend (− 0.6 h/month; 95% CI − 1.7, 0.5; p = 0.246) was maintained during the post-intervention period in the unadjusted segmented regression analysis.
Appendicular SMI was 5.96±0.72 before and 5.76±0.65 after the surgery, and although a decreasing trend was observed, there was no significant difference ( p =0.25).
On the other hand, it also appears to show a decreasing trend in the rate of recurrence of genital prolapse grade 2 or higher [RR: 0.59 (95% CI: 0.24–1.46) p = 0.25].
insanabilis gut compartments, with a decreasing trend from foregut (90.68%) > hindgut (80.36%) > midgut (68.33%) ( P = 0.25, Wilcoxon rank-sum test; Fig. 2 a).
In comparison to the control group (28.88 ± 13.27 nmol/L*min), the mean AUC for all three trial days showed a decreasing trend, with the smallest values for the studies performed on the 5th of September (22.9 ± 8.1 nmol/L*min, p = 0.25) and 28th of November 2018 (20.7 ± 10.7 nmol/L*min, n = 0.1684).
Diagnostic yield showed an upward trend (68.4% vs 57.9%; p=0.090) and alternative diagnoses a decreasing trend (7.0% vs 11.4%; p=0.252).
The rate of intrapartum cesarean section showed a decreasing trend in the D-DPEA group compared to EP (2.2% vs 7.8%, adjusted P = 0.255), but the difference was not statistically significant ( Table 2 ).
Additionally, Ht SDS BA in both treatment groups exhibited a decreasing trend compared to baseline, without statistically significant changes ( P = .259 and 0.138, respectively), suggesting that neither Pegpesen nor daily rhGH significantly accelerated BA growth or induced premature epiphyseal closure.
However, both showed a decreasing trend from 11.6% to 7.9% (p=0.26) and 5.1% to 2.6% (p=0.27), respectively, by 7–9 months post-ERATS compared to control.
Two meta-analyses ( 26 , 29 ) demonstrated that while limb numbness showed a decreasing trend in the TGP combination therapy group (OR = 0.38, 95% CI [0.07, 2.04]), the difference was not statistically significant ( p = 0.26; Figure 5 ). 3.1.12.
Likewise, we observed a decreasing trend in both G-CSF (75.1% reduction, P = 0.26) and GM-CSF (48.1% reduction, P = 0.08) release ( Fig. 4J ).
ndicating no significant difference; In adjusted attacks, the proportion increased from 12.86% to 13.84%, with a small increase and minimal change in the average, p = 0.55, indicating no significant difference; Secondary attacks accounted for the smallest proportion in both Olympic Games and showed a decreasing trend (2.00%, 1.50%), with a slight decrease in the mean, p = 0.26, indicating no significant difference; The proportion of spikes was 9.9% ( n = 124) in OG-20 and 10.50% ( n = 91) in OG-24, with almost no change in the mean, p = 0.72, no significant difference. 3.6.
Results from these statistical tests revealed that SBT participants showed an increasing trend in their reporting of malicious messages ( b = 0.21, p = 0.263, Odds Ratio ( OR ) = 1.23, 95% CI [0.56, 1.76]) and a decreasing trend in their reporting of benign, professional networking messages ( b = −0.09, p = 0.516, OR = 0.92, 95% CI [0.70, 1.20]) during skills-based training.
The expression of miR-412-5p, which was downregulated in multiple brain regions of AUD subjects, was on a decreasing trend (1.3-fold decrease & P = 0.263) in ethanol-exposed hESC-derived cortical interneurons.
However, post-NAT assessments showed a decreasing trend in ctDNA levels in the pCR group versus the non-pCR group (p=0.264), as well as in the MPR group versus the non-MPR group (p=0.170) ( figure 2b,c ).
Additionally, diastolic parameters such as the E/e′ ratio, showed a decreasing trend (p = 0.2731, Friedman test, n = 4), with baseline mean values at 8.0 ± 1.8, declining to 7.0 ± 1.3 during hypoxia, and further to 6.4 ± 1.4 during recovery.
The RMANOVA test results of that repeated measurements of UAS7 score in both groups during 8 weeks showed that although there is a decreasing trend, it was not statistically significant (P=0.275 in control group and 0.238 in intervention group).
The ctDNA clearance rate (ctDNA-clearance/[ctDNA-clearance + ctDNA-nonclearance]) showed a decreasing trend with advancing pathological stage: 47.73% (21/44) in stage II, 48.57% (17/35) in stage III, and 14.29% (1/7) in stage IVA patients ( p = 0.28) (Fig. 3 g).
Although there was a decreasing trend in the mean residual parasite genomic DNA levels from day 1 to day 3 (Fig. 4 B), the differences were not statistically significant ( P = 0.283).
While MMP13 mRNA showed a decreasing trend ( p = 0.284, one-way ANOVA with Tukey’s HSD post hoc test), its protein levels remained unchanged ( Figure 4f ).
For CV readmission risk, Kaplan–Meier curves showed a decreasing trend that failed to reach statistical significance ( P = 0.287).
The control group showed a decreasing trend in body weight between weeks 8 and 12 ( p = 0.29), whereas the treatment group showed a slightly increasing trend over the same period ( p = 0.74; Figure 3D ).
There was a decreasing trend of Pecam1 , Vegfa, and Hif1a expression in obese HFpEF mice vs obese Sham (P = 0.29; P = 0.22, and P = 0.11, respectively) ( Supplemental Figure 4 ).
Although not statistically significant, there was a decreasing trend in hazards of subsequent symptomatic infections among children with 1 or more prior infections (HR, 0.798 [95% CI, .524–1.215]; P = .293) and ≥2 prior infections (HR, 0.668 [95% CI, .381–1.172]; P = .159) (Table 3 ).